Addiction News and Research

RSS

NSU offers free dental services to victims of domestic violence

Nova Southeastern University (NSU) is offering free dental services to victims of domestic violence, who otherwise may not have access to such services.

3 Dec 2010

Quitting smoking eases symptoms of depression

Quitting smoking is certainly healthy for the body, but doctors and scientists haven't been sure whether quitting makes people happier, especially since conventional wisdom says many smokers use cigarettes to ease anxiety and depression. In a new study, researchers tracked the symptoms of depression in people who were trying to quit and found that they were never happier than when they were being successful, for however long that was.

3 Dec 2010

Smoking reduces brain thickness

Many brain imaging studies have reported that tobacco smoking is associated with large-scale and wide-spread structural brain abnormalities.

3 Dec 2010

AVMA condemns actions of animal rights activists against UCLA research neuroscientist

Citing its policy on the use of animals in research, testing and education, the American Veterinary Medical Association (AVMA) today condemned the recent actions of animal rights activists who have targeted a University of California research neuroscientist. The scientist's work includes the use of nonhuman primates to research biochemical factors that contribute to methamphetamine and tobacco addiction in adolescents, as well as to better understand cognitive problems that contribute to behavioral, speech and reasoning disabilities in schizophrenics.

2 Dec 2010

Timberline Knolls psychiatrist recommends patients to receive specialized care for co-occurring disorder

According to the American Psychiatric Association, at least three percent of the United States population has a co-occurring disorder, yet only eight percent of those suffering receive specialized treatment for both their mental illness and substance abuse disorders.

2 Dec 2010

New brain imaging technique can trace effects of SYN115 drug in Parkinson's disease

Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson's disease get into a patient's brain and affect blood flow in several key structures, an indicator the drug may be effective.

1 Dec 2010

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Neuroscientists at the Centre for Addiction and Mental Health (CAMH) have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression affects one in ten Canadians at some time in their lives and is a leading cause of disability worldwide.

30 Nov 2010

Molecular switch plays crucial role in addictive behavior and memory processes

Learning and memory formation are based on the creation of new connections between neurons in the brain. Also, behaviors such as nicotine addiction manifest themselves in long-term changes of neuronal connectivity and can - at least in this respect - be viewed as a form of learning.

30 Nov 2010

CRE comments on Addiction's menthol cigarettes Supplement

Addiction has published a Supplement for the month of December 2010 dealing with mentholated cigarettes.

26 Nov 2010

Léger Marketing survey shows substance abuse problems are major concern for Quebecers

More than one in eight Quebecers think drug and alcohol dependency problems are public health issues of concern. In the Léger Marketing survey "Quebecers and Substance Abuse," released today as part of Drug Awareness Week, half of respondents say they are affected by substance abuse problems among those around them.

26 Nov 2010

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

Researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ), following 10 years of studying tobacco use among smokers with mental illness, have developed a comprehensive strategy for recovery from smoking addiction that could serve as a nationwide model.

25 Nov 2010

Plant-derived bioscavenger protects against pesticide and nerve agent organophosphate poisoning

The brain is forever chattering to itself, via electrical impulses sent along its hard-wired neuronal "Ethernet." These e-messages are translated into chemical transmissions, allowing communication across the narrow cleft separating one neuron from another or between neurons and their target cells. Of the many kinds of molecules involved in this lively chemical symposium, acetylcholine is among the most critical, performing a host of functions in the central and peripheral nervous system.

24 Nov 2010

SAMHSA grants $14.4 million to help people in substance abuse treatment programs

The Substance Abuse and Mental Health Services Administration (SAMHSA) is announcing up to $14.4 million in new grants to help people in substance abuse treatment programs.

23 Nov 2010

Substance abuse treatment facilities offering nicotine replacement therapy increased by 6%: Report

The percentage of substance abuse treatment facilities offering nicotine replacement therapy to clients gradually increased by about 6 percentage points from 2006 to 2009, according to a new Spotlight report issued by the Substance Abuse and Mental Health Services Administration released in conjunction with the "Great American Smokeout."

19 Nov 2010

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.

19 Nov 2010

Titan Pharmaceuticals presents data on Probuphine Phase 3 clinical program for opioid addiction at Neuroscience Meeting

Titan Pharmaceuticals, Inc. today announced that data from its Phase 3 clinical development program for Probuphine were presented at the Society for Neuroscience Annual Meeting, being held Nov. 13-17 in San Diego.

18 Nov 2010

Studies explore lifestyle's influence on wellness and brain health

New research is providing a deeper understanding of how individual actions - such as exercising, sensory stimulation, or drinking - influence brain health and outcomes. This new knowledge could ultimately lead to interventions in age-related cognitive declines, drug abuse, stroke, and brain injury, separate from or in combination with traditional pharmacological approaches. These findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

17 Nov 2010

New OncoMap technique can detect point mutation in ovarian cancer

Researchers have shown that point mutations mis-spellings in a single letter of genetic code that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalised medicine in which every patient could have their tumour screened, specific mutations identified, and the appropriate drug chosen to target the mutation and halt the growth of their cancer.

17 Nov 2010

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Alkermes, Inc. today announced the presentation of promising preclinical results for its proprietary opioid modulator, ALKS 33, showing the drug candidate's potential in multiple disease indications.

17 Nov 2010

Today's Op-Eds: Congress needs conservative leadership; reviving tort reform; can states afford to drop Medicaid?

Nothing has gone quite so awry as the massive, government-run Obama health program, and it is plain that the individual mandate, the employee mandate, the abortion funding, the tangle of outsider/insider councils like the comparative effectiveness board and the effective nationalization of healthcare under grants of authority to the Department of Health and Human Services.

16 Nov 2010

Addiction News and Research

NSU offers free dental services to victims of domestic violence

Quitting smoking eases symptoms of depression

Smoking reduces brain thickness

AVMA condemns actions of animal rights activists against UCLA research neuroscientist

Timberline Knolls psychiatrist recommends patients to receive specialized care for co-occurring disorder

New brain imaging technique can trace effects of SYN115 drug in Parkinson's disease

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

Molecular switch plays crucial role in addictive behavior and memory processes

CRE comments on Addiction's menthol cigarettes Supplement

Léger Marketing survey shows substance abuse problems are major concern for Quebecers

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

Plant-derived bioscavenger protects against pesticide and nerve agent organophosphate poisoning

SAMHSA grants $14.4 million to help people in substance abuse treatment programs

Substance abuse treatment facilities offering nicotine replacement therapy increased by 6%: Report

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

Titan Pharmaceuticals presents data on Probuphine Phase 3 clinical program for opioid addiction at Neuroscience Meeting

Studies explore lifestyle's influence on wellness and brain health

New OncoMap technique can detect point mutation in ovarian cancer

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Today's Op-Eds: Congress needs conservative leadership; reviving tort reform; can states afford to drop Medicaid?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News